The underlying mechanism of ADAM9 in prostate cancer has also been discovered: ADAM9 can cleave and release epidermal growth factor and FGFR2iiib from cells, both of which play a key role in the pathogenesis of prostate cancer. The gene discussed is EGF; the disease is prostate carcinoma.